肠调节剂和肌缩侧面硬化症:目前的证据和未来的前景
Ahmed Noor Eddin1, Mohammed Alfuwais1, Reena Noor Eddin1
1College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.
Nutrients
|March 13, 2024
概括
肠道功能障碍和肠-大脑轴功能障碍与肌缩性侧面硬化症 (ALS) 有关. 准肠道微生物群通过解决炎症和代谢变化,显示出ALS的治疗潜力.
科学领域:
- 神经退行性疾病的神经退行性疾病
- 微生物学 微生物学
- 肠-大脑轴研究研究
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种致命的神经退行性疾病,治疗选择有限.
- 肠道疾病和肠-大脑轴 (GBA) 功能障碍越来越多地被认为是导致ALS的潜在贡献者.
- 在ALS患者中观察到肠道微生物组成的变化,与疾病进展相关.
研究的目的:
- 审查当前关于ALS肠道失调的文献.
- 探索GBA功能障碍在ALS病变发生中的作用.
- 检查微生物群调节剂对ALS的治疗潜力.
主要方法:
- 关于ALS,肠道微生物群和GBA的研究的综合文献综述.
- 对将肠道失调与ALS病理联系起来的机制的分析.
- 检查ALS模型中关于益生菌,益生菌和后生菌的临床前数据.
主要成果:
- 肠道失调有助于ALS通过损害肠道屏障完整性,代谢功能障碍和免疫失调.
- 临床前研究表明,针对ALS模型中的肠道微生物群具有神经保护作用.
- 调节肠道微生物群在动物模型中显示出缓解运动症状和减缓疾病进展的前景.
结论:
- 肠道功能障碍和GBA功能障碍是ALS的重要因素.
- 准肠道微生物群代表了对ALS的有希望的治疗途径.
- 需要进一步的研究来将动物模型的发现转化为人类ALS患者.
关键词:
骨髓缩性侧面硬化症 (ALS) 是一种疾病.这种疾病叫做dysbiosis.肠道调节是指肠道调节.肠-大脑轴 肠-大脑轴我们的微生物群.神经退行症的神经退行症益生菌是一种益生菌.治疗药物 治疗药物更多相关视频
10:49Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
Published on: September 18, 2011
20.6K
12:35Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
Published on: March 17, 2012
28.1K
相关概念视频
Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
670
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
670
Alzheimer's Disease: Treatment
186
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
186
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
